MannKind Corp. (MNKD)
3.955
-0.10
(-2.59%)
USD |
NASDAQ |
Aug 28, 16:00
3.955
0.00 (0.00%)
After-Hours: 20:00
MannKind Cash from Operations (Quarterly) : -18.63M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.63M |
| March 31, 2026 | -5.644M |
| December 31, 2025 | -7.428M |
| September 30, 2025 | 23.49M |
| June 30, 2025 | 8.774M |
| March 31, 2025 | -6.577M |
| December 31, 2024 | 22.53M |
| September 30, 2024 | 9.252M |
| June 30, 2024 | 3.731M |
| March 31, 2024 | 6.602M |
| December 31, 2023 | 21.63M |
| September 30, 2023 | 8.642M |
| June 30, 2023 | 2.553M |
| March 31, 2023 | 1.084M |
| December 31, 2022 | -2.394M |
| September 30, 2022 | -28.07M |
| June 30, 2022 | -31.98M |
| March 31, 2022 | -18.25M |
| December 31, 2021 | -12.35M |
| September 30, 2021 | -15.18M |
| June 30, 2021 | -21.45M |
| March 31, 2021 | -12.73M |
| December 31, 2020 | 0.235M |
| September 30, 2020 | -13.46M |
| June 30, 2020 | -3.684M |
| Date | Value |
|---|---|
| March 31, 2020 | -11.22M |
| December 31, 2019 | -5.107M |
| September 30, 2019 | -52.05M |
| June 30, 2019 | -19.73M |
| March 31, 2019 | -11.60M |
| December 31, 2018 | 24.99M |
| September 30, 2018 | -13.92M |
| June 30, 2018 | -27.15M |
| March 31, 2018 | -21.65M |
| December 31, 2017 | -29.98M |
| September 30, 2017 | -23.27M |
| June 30, 2017 | -20.03M |
| March 31, 2017 | 8.507M |
| December 31, 2016 | -12.75M |
| September 30, 2016 | -23.07M |
| June 30, 2016 | -11.51M |
| March 31, 2016 | -30.76M |
| December 31, 2015 | -23.38M |
| September 30, 2015 | -19.89M |
| June 30, 2015 | -17.81M |
| March 31, 2015 | 3.02M |
| December 31, 2014 | -35.74M |
| September 30, 2014 | 100.24M |
| June 30, 2014 | -23.42M |
| March 31, 2014 | -36.99M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| United Therapeutics Corp. | 310.20M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Gilead Sciences, Inc. | 3.573B |
| Vertex Pharmaceuticals, Inc. | 1.125B |
| Ocugen, Inc. | -12.20M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 17.91M |
| Cash from Financing (Quarterly) | 0.819M |
| Free Cash Flow | -18.30M |
| Free Cash Flow Per Share (Quarterly) | -0.0767 |
| Free Cash Flow to Equity (Quarterly) | -23.39M |
| Free Cash Flow to Firm (Quarterly) | -8.977M |
| Free Cash Flow Yield | -1.50% |